Aquestive Therapeutics, Inc. (AQST)
4.02
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
4.05
+0.03
(+0.75%)
After-Hours: 20:00
Aquestive Therapeutics Shareholders Equity (Quarterly) : -34.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 576.22M |
| Crinetics Pharmaceuticals, Inc. | 1.281B |
| Talphera, Inc. | 18.48M |
| Harrow, Inc. | 28.71M |
| Aytu Biopharma, Inc. | 35.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.12M |
| Total Liabilities (Quarterly) | 175.18M |
| Debt to Equity Ratio | -3.922 |
| Current Ratio | 4.100 |
| Net Debt Paydown Yield | -0.45% |